Russell Investments Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
39,085
+15,336
+65% +$552K ﹤0.01% 2334
2026
Q1
$840K Sell
23,749
-1,821
-7% -$74.1K ﹤0.01% 2297
2025
Q4
$1.04M Sell
25,570
-735
-3% -$32K ﹤0.01% 2211
2025
Q3
$1.24M Buy
26,305
+3,821
+17% +$198K ﹤0.01% 2109
2025
Q2
$1.17M Sell
22,484
-9,943
-31% -$546K ﹤0.01% 1990
2025
Q1
$1.96M Buy
32,427
+14,910
+85% +$961K ﹤0.01% 1710
2024
Q4
$1.2M Sell
17,517
-1,978
-10% -$138K ﹤0.01% 1920
2024
Q3
$1.4M Sell
19,495
-8,960
-31% -$632K ﹤0.01% 1874
2024
Q2
$1.97M Buy
28,455
+23
+0.1% +$1.68K ﹤0.01% 1640
2024
Q1
$2.28M Sell
28,432
-15,580
-35% -$1.39M ﹤0.01% 1585
2023
Q4
$4.82M Sell
44,012
-824
-2% -$85.2K 0.01% 1146
2023
Q3
$4.52M Sell
44,836
-373
-0.8% -$42.9K 0.01% 1132
2023
Q2
$6.14M Sell
45,209
-2,150
-5% -$262K 0.01% 1008
2023
Q1
$4.92M Buy
47,359
+10,531
+29% +$1.02M 0.01% 1113
2022
Q4
$3.26M Sell
36,828
-18,574
-34% -$1.54M 0.01% 1315
2022
Q3
$4.44M Buy
55,402
+866
+2% +$81.7K 0.01% 1116
2022
Q2
$5.22M Sell
54,536
-1,360
-2% -$163K 0.01% 1071
2022
Q1
$8.3M Sell
55,896
-6,429
-10% -$898K 0.01% 906
2021
Q4
$8.83M Sell
62,325
-1,136
-2% -$161K 0.01% 967
2021
Q3
$8.3M Buy
63,461
+5,778
+10% +$756K 0.01% 975
2021
Q2
$7.93M Sell
57,683
-1,540
-3% -$211K 0.01% 1065
2021
Q1
$7.73M Buy
59,223
+10,648
+22% +$1.28M 0.01% 1110
2020
Q4
$5.44M Sell
48,575
-15,928
-25% -$1.51M 0.01% 1196
2020
Q3
$5.07M Buy
64,503
+6,814
+12% +$556K 0.01% 1112
2020
Q2
$4.14M Sell
57,689
-9,977
-15% -$694K 0.01% 1209
2020
Q1
$3.86M Buy
67,666
+30,980
+84% +$2.86M 0.01% 1095
2019
Q4
$4.1M Sell
36,686
-14,731
-29% -$1.57M 0.01% 1333
2019
Q3
$4.94M Buy
51,417
+20,356
+66% +$1.91M 0.01% 1205
2019
Q2
$2.66M Hold
31,061
0.01% 1538
2019
Q1
$2.58M Buy
31,061
+9,404
+43% +$683K ﹤0.01% 1587
2018
Q4
$1.39M Sell
21,657
-2,085
-9% -$143K ﹤0.01% 1775
2018
Q3
$1.88M Hold
23,742
﹤0.01% 1794
2018
Q2
$1.74M Buy
+23,742
New +$1.61M ﹤0.01% 1834
2017
Q4
Sell
-17,363
Closed -$911K 2957
2017
Q3
$911K Sell
17,363
-51,253
-75% -$2.57M ﹤0.01% 2184
2017
Q2
$3.5M Sell
68,616
-11,870
-15% -$587K 0.01% 1420
2017
Q1
$3.57M Sell
80,486
-3,812
-5% -$164K 0.01% 1415
2016
Q4
$3.74M Buy
+84,298
New +$3.58M 0.01% 1419

Other funds holding CNMD

Russell Investments Group's CNMD Position: Q2 2026 in Review

Russell Investments Group increased its CONMED (CNMD) stake by 65% in Q2 2026, buying an estimated $552K and bringing the position to 39,085 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2334.

Russell Investments Group first reported a position in CNMD in Q4 2016 and has held it in 37 quarters since. The position peaked at $8.83M in Q4 2021. 101 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Russell Investments Group held 39,085 shares of CONMED worth $1.28M as of Q2 2026.
  • Russell Investments Group bought 15,336 CONMED shares in Q2 2026, an estimated $552K.
  • CONMED made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2334 holding.
  • Russell Investments Group first reported a position in CONMED in Q4 2016 and has held it in 37 quarters since.
  • Russell Investments Group's CONMED position peaked at $8.83M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.